Samit Hirawat - 01 Jul 2022 Form 4 Insider Report for BRISTOL MYERS SQUIBB CO (BMY)

Role: EVP,Chief Med.Offr.,Drug Dev.
Signature: /s/ Lisa A. Atkins, attorney-in-fact for Samit Hirawat
Issuer symbol: BMY
Transactions as of: 01 Jul 2022
Transactions value $: -$367,756
Form type: 4
Filing time: 05 Jul 2022, 16:28:08 UTC
Previous filing: 14 Mar 2022
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMY	Common Stock, $0.10 par value	Options Exercise	$0	+9,356	+55.95%	$0	26,078	01 Jul 2022	Direct	F1
transaction	BMY	Common Stock, $0.10 par value	Tax liability	-$367,756	-4,786	-18.35%	$76.84	21,292	01 Jul 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMY	Restricted Stock Units	Options Exercise	$0	-9,356	-50%	$0	9,357	01 Jul 2022	Common Stock, $0.10 par value	9,356		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock units vest in four equal installments beginning on July 1, 2020.
F2	Shares withheld for payment of taxes upon vesting of restricted stock units.
F3	Each restricted stock unit converts into one share of common stock upon vesting.